A carregar...

Activation of preexisting T cell clones by targeted interleukin 2 therapy

The induction of an immunological antitumor response capable of eradicating metastatic tumors is the ultimate goal of immunotherapy. We have recently shown that this can be achieved by interleukin 2 (IL-2) therapy directed to the tumor microenvironment by a recombinant antibody–IL-2 fusion protein....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: thor Straten, Per, Guldberg, Per, Seremet, Tina, Reisfeld, Ralph A., Zeuthen, Jesper, Becker, Jürgen C.
Formato: Artigo
Idioma:Inglês
Publicado em: The National Academy of Sciences 1998
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC21154/
https://ncbi.nlm.nih.gov/pubmed/9671756
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!